Physician profile
Edgar S Frey
NPI 1821100413
$4,765.73
in general payments reported to CMS, 2019-2025
22 companies · $921 in 2025
The $921 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $155 · 2021: $290 · 2022: $632 · 2023: $714 · 2024: $969 · 2025: $921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,405.72 | 2021-2025 | Phasix Mesh |
| Ethicon US, LLC | $554.18 | 2021-2025 | Vistaseal, Harmonic, Enseal |
| Intuitive Surgical, INC. | $434.44 | 2019-2024 | Da Vinci Surgical System |
| Conmed Corporation | $386.80 | 2019-2024 | Airseal, Conmed Pads and Pencils |
| Medical Device Business Services, INC. | $305.00 | 2019 | |
| Boston Scientific Corporation | $254.31 | 2019-2025 | Axios, Spyglass Discover |
| Baxter Healthcare | $191.38 | 2021 | |
| W. L. Gore & Associates, INC. | $145.08 | 2024 | Gore Synecor Biomaterial |
| Integra Lifesciences Corporation | $122.40 | 2023-2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Misonix INC | $122.12 | 2019 | |
| Acell, INC. | $119.28 | 2020 | |
| Angiodynamics, INC. | $113.43 | 2025 | Nanoknife |
| Acera Surgical, INC. | $102.71 | 2019 | |
| Springworks Therapeutics, INC. | $87.10 | 2024 | Ogsiveo |
| Osiris Therapeutics INC. | $78.68 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $72.07 | 2023 | Rapidvac, Sonicision |
| Kci USA, INC. | $70.81 | 2019-2022 | |
| Smith+Nephew, INC. | $54.89 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $54.23 | 2022 | |
| Tela Bio, INC. | $49.88 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Solventum Corporation | $24.94 | 2024 | Activ.A.C. |
| Teleflex LLC | $16.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.